Placebo-Controlled Randomized Study of KW-3902 for Subjects Hospitalized With Worsening Renal Function and Heart Failure Requiring IV Therapy
Clinical trial NCT00443690 · COMPLETED
Trial details
- NCT number
- NCT00443690
- Sponsor
- NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2009-01-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.